Govindan, R., Mandrekar, S. J., Kozono, D. E., Chaft, J. E., Gerber, D. E., Sands, J., Giri, S., Masters, G. A., Neal, J. W., Constantine, M., Bazhenova, L., Tan, A. D., Bradley, J. D., Gandara, D. R., Kelly, K., Ramalingam, S. S., Oxnard, G., Malik, S. M., Vokes, E. E., Stinchcombe, T. (2026). Adjuvant erlotinib versus observation after complete resection of
                    <i>EGFR</i>
                    -mutant NSCLC: Final overall survival results of Alliance A081105.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8001